The global lung stent market has witnessed substantial growth over the past few years due to the growing prevalence of lung cancer worldwide. Lung stents are medical devices that are implanted inside the airways or lungs to help keep them open in patients suffering from lung cancer, chronic obstructive pulmonary disease (COPD), and other conditions. They come in various sizes and designs depending on the size and nature of blockage in the lung. Some key advantages of lung stents include prevention of lung collapse, improvement in breathing, restoration of respiratory function, and ability to prolong life. With rising air pollution levels and growing smoking population globally, the incidence of lung cancer and other respiratory diseases have surged significantly, thereby augmenting the demand for lung stents.

The Global Lung Stent Market is estimated to be valued at US$ 206.5 million in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period of 2024 to 2031.

Key Takeaways
Key players operating in the global lung stent market are Boston Scientific, Cook Medical, Medtronic, Taewoong Medical, Hospitech, Bess, Endo-Flex, Efer Endoscopy, W. L. Gore & Associates, BD, Edwards Lifesciences, Healthy Medical Corporation, Pulmonx Corporation, Meril Life Sciences Pvt. Ltd and C. R. Bard Inc. Key players are mainly focused on developing novel lung stent designs and geometries to address unmet needs in the market.

The growing demand for effective treatment of lung cancer and other respiratory diseases has been a major driver for the Global Lung Stent Market Growth. According to the World Health Organization (WHO), lung cancer is the leading cause of cancer-related deaths globally and approximately 2.09 million new lung cancer cases were reported worldwide in 2020.

Geographically, North America dominates the global lung stent market owing to the high prevalence of lung cancer, rising healthcare expenditure, fast adoption of advanced technologies, and presence of key market players in the region. However, Asia Pacific is expected to exhibit the highest growth during the forecast period with growing medical tourism industry and increasing focus of global market players in developing countries.

Market drivers
The increasing incidence of lung cancer is a major factor driving the sales of lung stents globally. As per the American Cancer Society, lung cancer accounts for about 25% of all cancer deaths in the US and according to WHO, the total number of annual deaths from lung cancer worldwide will increase to over 3 million per annum by 2035. With effective diagnostics and advanced stent designs, the number of lung cancer treatments via stents is rising significantly, thus fueling the lung stent market growth. Additionally, rising geriatric population prone to age-related lung disorders, improving healthcare infrastructure, and favorable reimbursement policies are some other key factors boosting the global lung stent market.

Get more insights on This Topic- Global Lung Stent Market